Global X Cannabis ETF (POTX)

The week ending in February 15 featured the Exchange conference in Miami, Florida, and launches were muted as a result. Only one new ETF made its debut during the week.

One of the top-performing thematic segments this year is cannabis. A major catalyst has been the proposed descheduling of it from a Schedule I to a Schedule III drug under the Controlled Substances Ac...

Support for cannabis legalization reached all-time highs in 2023, creating a long list of cannabis stocks to buy. For one, a new Gallup survey found that 70% of Americans believe cannabis should be le...

Although 14 new ETFs debuted in the U.S. this past week, closure announcements came in even stronger, largely due to Global X pruning its lineup. Launches during the week included funds from BondBloxx...

Investing In Cannabis? Stay Patient, Be Ready

So far this month, Wall Street remained almost flat. But a few ETF areas have been hovering at around a month-high and have been still gaining strength.

Cannabis stocks will eventually see higher highs — with patience. Right now, we're waiting to see if the Drug Enforcement Administration (DEA) takes the U.S. Department of Health and Human Services' (...

Cannabis stocks may be one of the most controversial trades on the market. But it could also turn out to be one of the most profitable.

Like any recovering reporter, I like to keep tabs on my old beats, and the marijuana ETF space never disappoints. Or, perhaps more accurately, it never stops disappointing.

Cannabis stocks are in focus after the Secure and Fair Enforcement Regulation Banking Act moved forward in the upper chamber of Congress on Wednesday. What the renegotiated SAFER means for cannabis co...